Vertex Pharmaceuticals holds the cleaner structural position, with profitability as the main driver and stability adding further support. Amgen still has the edge on growth, which keeps the comparison from looking entirely one-sided. The market setup is currently leaning toward Amgen, which does not confirm the structural lead. That leaves a split case: the structural lead stays with Vertex Pharmaceuticals, but the market is not currently confirming it.
The comparison is based on similar long-term financial trajectories, not sector labels.
This is not just a one-metric split: both profitability and stability materially support the lead. The overall score gap is 8 points in favour of Vertex Pharmaceuticals Incorporated.
This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.
A moderate similarity means the pair is structurally comparable, but not a near-twin trajectory match.
Most of the shared profile comes through investment intensity and revenue growth trajectory.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The largest gaps do not all point in the same direction.
Left means cheaper relative valuation. Higher means stronger structure.
The price setup looks more supportive for Vertex Pharmaceuticals Incorporated, but Amgen Inc. still has the stronger structure.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
The profitability lead is mainly driven by a 9.1-point operating margin advantage.
Earnings growth also leans the other way, which keeps the score lead from reading as a full growth sweep.
Profitability is the clearest driver of the lead, with stability adding further support — though growth still provides a real counterweight.
Break down the AMGN vs VRTX comparison across all dimensions with the full interactive tool.
Explore how AMGN and VRTX each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.